| ¿µ¹® | plasma membrane | ÇÑ±Û | ÇüÁú¸· |
|---|---|---|---|
| ¼³¸í | ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀÇ Ç¥¸é Ȱ¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯ÇÏ¸é ±× Åõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù. |
||
| ¿µ¹® | neurotransmitter | ÇÑ±Û | ½Å°æÀü´Þ¹°Áú |
|---|---|---|---|
| ¼³¸í | ü³»ÀÇ ½Å°æ ¼¼Æ÷¿¡¼ ¹æÃâµÇ¸ç ÀÎÁ¢ÇÏ´Â ½Å°æ¼¼Æ÷³ª ±ÙÀ°¿¡ Á¤º¸¸¦ Àü´ÞÇÏ´Â ¹°Áú. ½Å°æ¼¼Æ÷³»¿¡¼ ÇÕ¼ºµÇ¾î¼ ½Å°æÁ¾¸»ÀÇ ¿¬Á¢¼ÒÆ÷¿¡ ÀúÀåµÈ´Ù. Àڱؿ¡ ÀÇÇØ¼ ¿¬Á¢°£±Ø¿¡ À¯¸®µÇ¾î¼ ¼ö¿ëü¿Í °áÇÕÇÏ¿© Á¤º¸¸¦ ´ÙÀ½ ¼¼Æ÷·Î ÀüÇÑ´Ù. Àü±âÀûÀ¸·Î°¡ ¾Æ´Ï¶ó ÈÇй°Áú¿¡ ÀÇÇØ¼ ¿¬Á¢°£±ØÀ» °ÅÃÄ Á¤º¸¸¦ ÀüÇϱ⠶§¹®¿¡ ÈÇÐÀü´Þ¹°ÁúÀ̶ó°íµµ ÇÑ´Ù. ¿¬Á¢Èĸ·(°æ¿ì¿¡ µû¶ó¼ ¿¬Á¢Àü¸·)À» ÈïºÐ(Å»ºÐ±Ø)½ÃŰ´Â ÈïºÐ¼ºÀü´Þ¹°Áú°ú ¾ïÁ¦(°úºÐ±Ø)ÇÏ´Â ¾ïÁ¦¼º Àü´Þ¹°ÁúÀÌ ÀÖ´Ù. ¾Æ¼¼Æ¿Äݸ°, ³ë¸£¿¡Çdz×ÇÁ, µµÆÄ¹Î, ±Û¸®½Å, ¥ã-¾Æ¹Ì³ëºäÄ¥»ê(GABA)µî °°Àº ½Å°æÀü´Þ¹°ÁúÀÌ¶óµµ ¼ö¿ëü¿¡ µû¶ó¼ ÈïºÐ¼º°ú ¾ïÁ¦¼ºÀ¸·Îµµ ÀÛ¿ëÇÏ´Â °Íµµ ÀÖ´Ù. |
||
| ¿µ¹® | serum proteins | ÇÑ±Û | Ç÷û´Ü¹é |
|---|---|---|---|
| ¼³¸í | Ç÷û¿¡ ÀÖ´Â ´Ü¹éÁúµéÀ» ÃÑĪÇÏ´Â ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | plasma | ÇÑ±Û | Ç÷Àå |
|---|---|---|---|
| ¼³¸í | Ç÷¾×À̳ª ¸²ÇÁ¾×ÀÇ ¾×ü ºÎºÐÀ» ¸»Çϴµ¥, ÁÖ·Î Ç÷¾×¿¡¼ °íÇü¼ººÐ(Ç÷±¸¼¼Æ÷)À» Á¦¿ÜÇÑ ¾×ü ºÎºÐÀ» ÀǹÌÇÑ´Ù. ¿©±â¿¡´Â ´Ü¹é¼ººÐ(¸é¿ªÇö»óÀ» À¯¹ßÇÏ´Â Ç×ü¸¦ Æ÷ÇÔÇÔ), ¿µ¾ç¼ººÐ(°¢ ¼¼Æ÷¿¡ ¿µ¾çºÐÀ» °ø±ÞÇÔ), ±×¸®°í Ç÷¾×ÀÀ°í ¼ººÐ(»óó°¡ ³µÀ» ¶§ ÃâÇ÷ÀÌ ¸ÜÀ» ¼ö ÀÖµµ·Ï ÇÔ) µîÀÌ Æ÷ÇԵȴÙ. |
||
| TM | technology management; tectorial membrane; temperature by mouth; temporalis muscle; temporomandibula... |
|---|---|
| NT, Nt | NeuroTransmitter |
| BNT | Boston Naming Test; brain neurotransmitter |
| SCM | Schwann cell membrane; sensation, circulation, and motion; Society of Computer Medicine; soluble cyt... |
| PM | after death (Lat. post mortem); after noon [Lat. post meridiem]; mean pressure; pacemaker; pantomogr... |
| G proteins | GIP-binding proteins |
|---|---|
| G-proteins | GTP)-binding regulatory proteins |
| G-proteins | Guanine nucleotide-binding regulatory proteins |
| G proteins | reglatory proteins |
| MP | Membrane proteins |
| cholesterol ester transport proteins | A protein that transports cholesterol esters from HDL to VLDL and LDL; a deficiency of this protein is associated with elevated HDL cholesterol. (05 Mar 2000) |
|---|---|
| monosaccharide transport proteins | Membrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium atpase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin b, and inhibitors of the sodium potassium atpase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell. (12 Dec 1998) |
| membrane transport | <cell biology> The transfer of a substance from one side of a plasma membrane to the other, in a specific direction and at a rate faster than diffusion alone. See: active transport. (18 Nov 1997) |
| plasma proteins | Dissolved protein's (more than 100) of blood plasma, mainly albumins and globulins (normally 6 to 8 g/100 ml); they hold fluid in blood vessels by osmosis and include antibodies and blood-clotting protein's. Synonym: serum proteins. (05 Mar 2000) |
| apical plasma membrane | <cell biology> The term used for the cell membrane on the apical (inner or upper) surface of transporting epithelial cells. This region of the cell membrane is separated, in vertebrates, from the baso lateral membrane by a ring of tight junctions that prevents free mixing of membrane proteins from these two domains. (18 Nov 1997) |
| basolateral plasma membrane | <cell biology> The plasma membrane of epithelial cells that is adjacent to the basal lamina or the adjoining cells of the sheet. Differs both in protein and phospholipid composition from the apical plasma membrane from which it is isolated by tight junctions (zonula occludentes). (18 Nov 1997) |
| plasma membrane | <cell biology> The external, limiting lipid bilayer membrane of cells. (31 Dec 1997) |
| receptors, neurotransmitter | Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. (12 Dec 1998) |
| peptide neurotransmitter | Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide. (18 Nov 1997) |
| neurotransmitter | Any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, y aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin. (18 Nov 1997) |
| neurotransmitter agents | Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (12 Dec 1998) |
| neurotransmitters and neurotransmitter agents | A collective grouping for neurotransmitters and substances that act on the neurotransmitter system. (12 Dec 1998) |
| neurotransmitter system | A group of nerve cells that use the sameneurotransmitter to communicate. (22 May 1997) |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
| bacterial outer membrane proteins | Proteins isolated from the outer membrane of bacteria. (12 Dec 1998) |
Synonyms : Plasma Membrane Neurotransmitter Transporter Proteins, Plasma Membrane Neurotransmitter Transporters, Sodium Chloride-Dependent Neurotransmitter Symporters, Sodium-Neurotransmitter Symporters, Sodium Chloride Dependent Neurotransmitter Symporters
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|